Click on the link below. The Baker & Young report is a good summary read. The report is dated Feb 2021 however the report is still relevant.
https://paradigmbiopharma.com/wp-content/uploads/2022/05/Baker-Young-Research-Report-February-2021-.pdf
The report covers the drug and company background, the OA market opportunity, high level summary of the science etc. Once you have digested the report then you can bring yourself up to date by reading the latest company announcements. There are many posters on this forum including Mozz you can then read up on and follow.
Click on the link below. The Baker & Young report is a good...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |